Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
about
Venous thromboembolic diseaseTamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomyTamoxifen-associated Budd-Chiari syndrome complicated by heparin-induced thrombocytopenia and thrombosis: a case report and literature reviewOsteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.Cerebral venous thrombosis in a breast cancer patient taking tamoxifen: Report of a case.Estrogens and selective estrogen receptor modulators regulate gene and protein expression in the mesenteric arteriesHormonal breast cancer agents: implications for the primary care provider.Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy.Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancerLinks between arterial and venous disease.Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.Clinical practice decisions in endocrine therapy.Early recurrence risk: aromatase inhibitors versus tamoxifen.Unique aspects of caring for young breast cancer patients.Cardiovascular disease in cancer survivors.Breast cancer treatment-induced cardiotoxicity.Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.Sex differences in thrombosis.Tamoxifen Use Correlates with Increased Risk of the First Episode of Ischemic Cerebrovascular Disease in Older Women with Breast Cancer: A Case-Control Study in Taiwan.Long-Term and Latent Side Effects of Specific Cancer Types.Venous thromboembolism and the risk of subsequent symptomatic atherosclerosisNo increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
P2860
Q24631121-5D51FA67-2C90-4EF1-A35E-5D507377C4BBQ28300092-D5827560-77D3-4DE5-978B-EEF30EA850DAQ33404691-145A0E94-EF7A-441B-B7F4-A429E2E92B4FQ34005811-1CD5A38F-7C8A-45A8-9239-DFA3FABE5445Q34130749-6AFB41FC-0D4B-422E-BA12-577ABADD6745Q35101978-CA1BCB3C-3D80-4794-ABBE-A53E3BD22B83Q35175559-BD178FE3-02FA-43A3-B17E-C7E8283C13A0Q36634394-05BB64E6-764D-42B5-90B9-2C27ECA07D5BQ36689195-E034592E-791F-436F-8481-5CCD3682CEC8Q36900784-F6F075CA-5469-4E56-90D6-1A6FBD688869Q36909570-E6110FB9-5179-4741-AD30-1EC12C21F5C9Q37008398-11FE0033-A45C-42E9-87D3-7B105C13DDA7Q37311501-6F9583EF-EDBC-452B-9D01-94B6DD7E6CDAQ37775019-F230581C-0349-4C88-B6A4-CB9C1C4CC295Q37782092-2616E010-82D1-40FA-B371-BA6E75B446B6Q38341795-15954A92-F2D5-48F7-B356-5A737C2DAE8AQ39103481-7B6065FC-1A00-42DA-9824-34DBBD8EDF07Q39428826-296CB24C-82E9-4D3D-B7ED-6A3079D20FF9Q40606927-7B8B4380-D570-4B72-B683-2C978A6E9AE3Q42807454-0B9F94EA-7CD9-4645-9FD1-97A58088E269Q44328480-87E1F8D4-3BD4-4C2A-B834-C5B05EEA484DQ47602301-82FF95B5-51FB-4F57-A83A-D7F3F8A59C64Q57300702-CEED1A44-A64F-4E2A-8263-315E21C354A7Q58215078-3252F24E-0546-4AEE-B622-492CC6C66F93
P2860
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@ast
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@en
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@nl
type
label
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@ast
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@en
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@nl
prefLabel
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@ast
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@en
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
@nl
P2093
P50
P1433
P1476
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial
@en
P2093
Alberto Costa
Alessandro Salvioni
Andrea Decensi
Bernardo Bonanni
Donato Bettega
Giacomo Gucciardo
Giuseppe D'Aiuto
Italian Tamoxifen Study Group
Marcella Gulisano
Marco Rosselli del Turco
P304
P356
10.1161/01.CIR.0000154545.84124.AC
P407
P577
2005-02-01T00:00:00Z